News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Wave Life Sciences Ltd. - Ordinary Shares
(NQ:
WVE
)
15.54
-0.80 (-4.90%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Wave Life Sciences Ltd. - Ordinary Shares
< Previous
1
2
3
4
5
6
7
Next >
In today's session, these stocks are experiencing unusual volume.
↗
December 11, 2025
In today's session, these stocks are experiencing unusual volume.
Via
Chartmill
Golden Cross Alert: 3 Stocks With Major Upside Potential
↗
December 10, 2025
Via
MarketBeat
Why Wave Life Sciences Stock Crushed it Again Today
↗
December 09, 2025
There's nothing like a nearly 150% price gain to garner the attention of investors and analysts.
Via
The Motley Fool
Which stocks have an unusual volume on Tuesday?
↗
December 09, 2025
Discover the stocks with unexpected trading volume in today's session on the US markets.
Via
Chartmill
The 2025 Weight-Loss Drug Gold Rush: How Eli Lilly Pulled Ahead, Novo Hit A Snag — And A Swarm Of Biotech Underdogs Are Closing In
↗
December 09, 2025
Via
Stocktwits
Wave Life Sciences Stock Rockets 120% After Obesity Drug Shows Deep Fat Reduction, Muscle Gain — Traders See A ‘Blockbuster' Candidate
↗
December 08, 2025
Via
Stocktwits
Earnings Scheduled For November 10, 2025
↗
November 10, 2025
Via
Benzinga
Peering Into WAVE Life Sciences's Recent Short Interest
↗
September 12, 2025
Via
Benzinga
Why Structure Therapeutics Stock Doubled and Then Some on Monday
↗
December 08, 2025
The company's investigational GLP-1 treatment performed admirably well in a phase 2b study.
Via
The Motley Fool
Why Wave Life Sciences Stock Vaulted 146% Higher on Monday
↗
December 08, 2025
We have an emerging new entrant in the increasingly crowded weight loss drug space.
Via
The Motley Fool
Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More
↗
December 08, 2025
Via
The Motley Fool
What's going on in today's session
↗
December 08, 2025
Wondering how the US markets performed in the middle of the day on Monday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via
Chartmill
Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Why
↗
September 03, 2025
Via
Stocktwits
There are notable gap-ups and gap-downs in today's session.
↗
December 08, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Monday.
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
December 08, 2025
Wondering what's happening in Monday's pre-market session? Find an overview in this article.
Via
Chartmill
Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
December 03, 2025
December 3, 2025 – Capricor Therapeutics (NASDAQ: CAPR) has sent shockwaves through the biotech sector today, witnessing an astonishing 535% surge in its stock price, propelling the company to an...
Via
MarketMinute
These Analysts Revise Their Forecasts On Wave Life Sciences Following Q3 Results
↗
November 11, 2025
Via
Benzinga
Wave Life Sciences (WVE) Earnings Transcript
↗
November 10, 2025
Wave Life Sciences (WVE) Earnings Transcript
Via
The Motley Fool
Wave Life Sciences Ltd (NASDAQ:WVE) Reports Q3 2025 Earnings Miss, Stock Falls
↗
November 10, 2025
Wave Life Sciences reported mixed Q3 2025 results, missing on revenue and EPS. Despite the financial miss, the biotech highlighted strong clinical progress for its obesity and AATD programs.
Via
Chartmill
Topics
Earnings
Biotech Sector Soars: Promising Drug Trials Ignite Investor Confidence and Spark Market Rally
November 07, 2025
The biotech sector is currently experiencing a robust rally, a significant turnaround from a period of subdued performance. This resurgence is primarily fueled by a wave of promising drug trial results...
Via
MarketMinute
Topics
Artificial Intelligence
Intellectual Property
A Look Ahead: WAVE Life Sciences's Earnings Forecast
↗
November 07, 2025
Via
Benzinga
Keep an eye on the top gainers and losers in Wednesday's session.
↗
October 29, 2025
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 29, 2025
Via
Benzinga
Deep Dive Into WAVE Life Sciences Stock: Analyst Perspectives (6 Ratings)
↗
October 15, 2025
Via
Benzinga
Top movers analysis one hour before the close of the markets on 2025-09-03: top gainers and losers in today's session.
↗
September 03, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
Forecasting The Future: 7 Analyst Projections For WAVE Life Sciences
↗
September 03, 2025
Via
Benzinga
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?
↗
September 03, 2025
Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 03, 2025
Via
Benzinga
Crude Oil Falls Over 2%; Campbell's Earnings Top Estimates
↗
September 03, 2025
Via
Benzinga
Wednesday's session: gap up and gap down stocks
↗
September 03, 2025
Today's session on Wednesday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
